Product Description

Tesamorelin – Visceral Fat Reduction & Body Composition Peptide Therapy

Tesamorelin is a growth hormone-releasing factor (GHRF) analog peptide specifically developed to target visceral fat reduction while supporting lean muscle preservation. (Think “biohacking”!)Unlike general weight loss peptides, Tesamorelin is designed to improve body composition by reducing abdominal fat—one of the most metabolically active and health-risk-associated fat deposits—without altering subcutaneous fat or lean muscle mass.

Visceral fat accumulation is linked to insulin resistance, chronic inflammation, cardiovascular risk, and metabolic syndrome. Tesamorelin supports metabolic health and body composition optimization by stimulating the pituitary gland to release growth hormone in a controlled, physiologically appropriate manner.

How Tesamorelin Works

Tesamorelin functions by enhancing endogenous GH secretion in a pulsatile and controlled manner. Its mechanisms of action include:

• Stimulating natural growth hormone release from the pituitary gland
• Promoting lipolysis specifically in visceral fat stores
• Preserving lean muscle mass during fat reduction
• Supporting metabolic efficiency and insulin sensitivity
• Enhancing protein synthesis and tissue regeneration

Unlike exogenous growth hormone therapy, Tesamorelin minimizes systemic IGF-1 spikes while still delivering clinically meaningful improvements in abdominal fat reduction and metabolic health.

Benefits of Tesamorelin Therapy

Patients using Tesamorelin typically report:

• Significant reduction in visceral abdominal fat
• Enhanced lean body mass retention
• Improved metabolic markers, including insulin sensitivity
• Improved waist circumference and body composition
• Increased energy, vitality, and physical performance

Tesamorelin is particularly popular among biohackers and individuals committed to long-term body composition optimization, as its effects support both aesthetics and metabolic health.

Administration and Protocol

Tesamorelin is administered via subcutaneous injection. Clinical protocols typically involve:

• 1 mg daily injection
• 5 days per week
• 12-week (3-month) supply, billed monthly

This structured approach allows patients to maintain consistent dosing, monitor progress, and adjust therapy as needed.

Ideal Candidates

Tesamorelin is appropriate for individuals who:

• Have stubborn visceral fat resistant to diet and exercise
• Are seeking metabolic optimization alongside body composition improvement
• Want a medically supervised peptide therapy to reduce abdominal fat
• Are engaged in lifestyle or biohacking programs targeting longevity and metabolic health

Quality and Compounding

Tesamorelin is compounded to strict pharmaceutical standards, ensuring purity, stability, and consistent dosing. Medical oversight ensures safe administration and monitoring of metabolic effects.

Medication plan is personalized to your clinical goals and monitored by a licensed provider.

This medicine is available only with prescription.

Here at Revive we require a comprehensive consultation and approval by our provider prior to prescription and/or Tesamorelin injection. 

Additional information